Erdafitinib - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Quinoxaline owl:NamedIndividual Experimental cancer drug Johnson & Johnson brand Protein kinase inhibitor Drug granted breakthrough therapy designation Pyrazole
rdfs:label	Erdafitinib
owl:sameAs	dbr:Erdafitinib
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Johnson_&_Johnson_brands http://en.wikipedia.org/wiki/Category:Experimental_cancer_drugs http://en.wikipedia.org/wiki/Category:Pyrazoles http://en.wikipedia.org/wiki/Protein_kinase_inhibitor http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Protein_kinase_inhibitors http://en.wikipedia.org/wiki/Category:Quinoxalines
skos:prefLabel	Erdafitinib
skos:altLabel	erdafitinib
clgo:alternativeName	Balversa
clgo:casNumber	1346242-81-6
clgo:chEMBL	3545376
clgo:drugbank	DB12147
clgo:fdaUniiCode	890E37NHMV
clgo:kegg	D10927
clgo:medlinePlus	a619031
clgo:pubchem	67462786

About: clgr:Erdafitinib